About Cannevert Therapeutics
Cannevert Therapeutics is a company based in Vancouver (Canada) founded in 2014 was acquired by Veritas Pharma in April 2017. Cannevert Therapeutics operates in a competitive market with competitors including Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, Karuna Therapeutics and Kriya Therapeutics, among others.
- Headquarter Vancouver, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Veritas Pharma
(Apr 21, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Cannevert Therapeutics
Detailed funding history for Cannevert Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Cannevert Therapeutics
Cannevert Therapeutics has secured backing from 1 investor. Prominent investors backing the company include Veritas Pharma Inc.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Veritas Pharma is a discovery company focused on developing new medicinal cannabis cultivars for specific diseases.
|
Locked | Locked | Locked |
Investor details for Cannevert Therapeutics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Cannevert Therapeutics
Investment portfolio details for Cannevert Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Cannevert Therapeutics
Detailed financials for Cannevert Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Cannevert Therapeutics Comparisons
Peer comparison for Cannevert Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Cannevert Therapeutics
Cannevert Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Lundbeck, Sana Biotechnology, Karuna Therapeutics and Kriya Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| Locked | Locked | Locked |
Drugs for CNS disorders are developed and advanced.
|
|
| Locked | Locked | Locked |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| Locked | Locked | Locked |
Therapies for psychosis and cognitive impairment are developed.
|
|
| Locked | Locked | Locked |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| Locked | Locked | Locked |
Immunotherapeutics are developed for inflammation, fibrosis, and lung diseases.
|
Detailed competitors of Cannevert Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Cannevert Therapeutics
Complete news archive for Cannevert Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Cannevert Therapeutics
Cannevert Therapeutics was founded in 2014.
Cannevert Therapeutics is headquartered in Vancouver, Canada. It is registered at Vancouver, British Columbia, Canada.
Lui Franciosi is the current CEO of Cannevert Therapeutics.
Cannevert Therapeutics was founded in 2014 in Vancouver, Canada, to examine cannabis cultivars scientifically for medical applications. Research focuses on chemical profiling of extracts using analytical methods, including heat-processed versions, followed by animal testing for efficacy against chronic conditions like pain, nausea, depression, and anxiety in cancer or AIDS patients. A partnership with Veritas Pharma was established, and an exemption from Health Canada for cannabis studies was obtained in 2016.
Cannevert Therapeutics's top competitors include Jazz Pharmaceuticals, Neurocrine and Biohaven Pharmaceutical.
Cannevert Therapeutics has 1 investor. Key investors include Veritas Pharma Inc.